Lai et al. illustrated that blocking the bFGF/PI3K/Akt signaling pathway (using pathway inhibitors LY294002 and naringenin) inhibited HIF-1α expression to reduce HCC radiotherapy resistance [52]. Here, AKT1 is linked to hepatocellular carcinoma.